Table I.
Patient baseline demographics.
| Variable | Patient no.a (%) |
|---|---|
| Age, years (mean ± SD) | 66.3±7.6 |
| Gender | |
| Male | 29 (93.5) |
| Female | 2 (6.5) |
| ECOG PS | |
| 0–1 | 25 (80.6) |
| 2 | 6 (19.4) |
| Primary tumour site | |
| Larynx | 11 (35.5) |
| Hypopharynx | 20 (64.5) |
| Tumour distribution | |
| T2 | 12 (38.7) |
| T3 | 13 (41.9) |
| T4 | 6 (19.4) |
| Lymph node distribution | |
| N0 | 5 (16.1) |
| N1 | 4 (12.9) |
| N2a | 4 (12.9) |
| N2b | 11 (35.5) |
| N2c | 7 (22.6) |
| No. of chemotherapy cycles (mean ± SD) | 2.9±1.4 |
a
Total patient no. was 31. SD, standard deviation; ECOG, Eastern Cooperative Oncology Group; PS, performance status.